XU Xin, LI Na, SANG Ni, ZHU Zihui, QIN Xian, HAN Qianqian, ZHANG Jingjing, ZHU Ling. Application of nurse-patient interaction integrated APP in patients with neuroendocrine tumors treated with long-acting octreotide[J]. Journal of Clinical Medicine in Practice, 2023, 27(22): 127-130, 137. DOI: 10.7619/jcmp.20232687
Citation: XU Xin, LI Na, SANG Ni, ZHU Zihui, QIN Xian, HAN Qianqian, ZHANG Jingjing, ZHU Ling. Application of nurse-patient interaction integrated APP in patients with neuroendocrine tumors treated with long-acting octreotide[J]. Journal of Clinical Medicine in Practice, 2023, 27(22): 127-130, 137. DOI: 10.7619/jcmp.20232687

Application of nurse-patient interaction integrated APP in patients with neuroendocrine tumors treated with long-acting octreotide

More Information
  • Received Date: August 23, 2023
  • Revised Date: November 21, 2023
  • Available Online: December 05, 2023
  • Objective 

    To develop a nurse-patient interaction integrated APP "NET Home" to provide detailed care and follow-up management for patients with neuroendocrine tumors (NENs) treated with long-acting octreotide.

    Methods 

    "NET Home" APP included three ports: patient side, medical side and management side. After discharge, NENs patients timely and comprehensive fed back on adverse reactions and discomfort symptoms through APP, and medical staff timely guided patients to deal with them online.

    Results 

    At 1 year after "NET Home" APP application, 45 patients registered (injected with long-acting octreotide once every 28 days). A total of 145 copies of Micro-nutrition Evaluation Scales, 147 Tumor Patients' Quality of Life Rating scales, 102 Pain Digital Evaluation Scales, 103 Adverse Reactions Questionnaire of Long-acting Octreotide Injection, 102 Self-care Ability Scales, 111 Self-rating Scales for depression and 102 Self-rating Scales for anxiety were collected. The medical staff treated 5 cases of adverse reactions by APP, and gave timely handling to 1 case of severe adverse reactions (the patient eventually stopped long-acting octreotide therapy). Compared with NENs patients who did not use APP, anxiety scores of NENs patients who used APP decreased (P < 0.05); their satisfaction scores and quality of life scores were improved, and the number of unplanned admissions decreased, but the differences showed no statistically significant (P > 0.05).

    Conclusion 

    "NET Home" APP can realize refined and personalized nursing intervention through multiple module functions, which can realize continuous home care for NENs patients, relieve their anxiety and improve their self-management ability, quality of life and treatment compliance.

  • [1]
    杨欢, 王晓坤, 石素胜, 等. 不同年龄胃肠胰神经内分泌肿瘤患者预后分析[J]. 中国肿瘤临床, 2022, 49(15): 792-796. doi: 10.12354/j.issn.1000-8179.2022.20220089
    [2]
    DASARI A, SHEN C, HALPERIN D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States[J]. JAMA Oncol, 2017, 3(10): 1335. doi: 10.1001/jamaoncol.2017.0589
    [3]
    CIVES M, STROSBERG J R. Gastroenteropancreatic neuroendocrine tumors[J]. CA Cancer J Clin, 2018, 68(6): 471-487. doi: 10.3322/caac.21493
    [4]
    SHAH M H, GOLDNER W S, HALFDANARSON T R, et al. NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2. 2018[J]. J Natl Compr Canc Netw, 2018, 16(6): 693-702. doi: 10.6004/jnccn.2018.0056
    [5]
    中国抗癌协会神经内分泌肿瘤专业委员会. 中国抗癌协会神经内分泌肿瘤整合诊治指南(精简版)[J]. 中国肿瘤临床, 2023, 50(8): 385-397. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL202317002.htm
    [6]
    高鹤丽, 徐近, 虞先濬. 2021年胰腺神经内分泌肿瘤诊治的新进展[J]. 中国癌症杂志, 2022, 32(9): 772-778. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ202209003.htm
    [7]
    甘恬田, 张长霞, 姚晓琴. 胰腺神经内分泌肿瘤病人手术后应用长效奥曲肽的护理效果分析[J]. 实用临床护理学电子杂志, 2019, 4(23): 34-34, 42. https://www.cnki.com.cn/Article/CJFDTOTAL-SLHL201923027.htm
    [8]
    CAPLIN M E, PAVEL M, CWIKŁA J B, et al. Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study[J]. Endocr Relat Cancer, 2016, 23(3): 191-199. doi: 10.1530/ERC-15-0490
    [9]
    CAPLIN M E, PAVEL M, PHAN A T, et al. Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study[J]. Endocrine, 2021, 71(2): 502-513. doi: 10.1007/s12020-020-02475-2
    [10]
    李明明, 白岩. 醋酸奥曲肽微球联合吉西他滨对胃肠胰神经内分泌肿瘤患者血清激素、肿瘤标志物水平及预后的影响[J]. 检验医学与临床, 2022, 19(16): 2250-2255. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYL202216023.htm
    [11]
    PAVEL M, CWIKŁA J B, LOMBARD-BOHAS C, et al. Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: clarinet FORTE phase 2 study results[J]. Eur J Cancer, 2021, 157: 403-414. doi: 10.1016/j.ejca.2021.06.056
    [12]
    孔颖, 黄婷, 沈萌. 基于移动医疗App的延续性护理对慢性鼻窦炎患者的影响[J]. 齐鲁护理杂志, 2020, 26(3): 32-35. https://www.cnki.com.cn/Article/CJFDTOTAL-QLHL202003013.htm
    [13]
    陈晓敏, 胡英杰, 陈玲, 等. 基于移动医疗的孕期盆底肌训练方案的构建[J]. 中国全科医学, 2020, 23(30): 3806-3811. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202030008.htm
    [14]
    张瑞玲, 王玉英, 郭建琳, 等. 基于移动医疗APP的HIV感染病人远程延续护理模式的构建与应用[J]. 护理研究, 2022, 36(3): 517-521. https://www.cnki.com.cn/Article/CJFDTOTAL-SXHZ202203026.htm
    [15]
    HWANG R, MORRIS N R, MANDRUSIAK A, et al. Cost-utility analysis of home-based telerehabilitation compared with centre-based rehabilitation in patients with heart failure[J]. Heart Lung Circ, 2019, 28(12): 1795-1803.
    [16]
    尹瑶, 陈红. 痛风病人自我管理移动医疗应用程序研究进展[J]. 护理研究, 2021, 35(16): 2926-2929. https://www.cnki.com.cn/Article/CJFDTOTAL-SXHZ202116021.htm
  • Related Articles

    [1]SUN Danghong, DAI Li, XU Tingting, MENG Jie, ZHU Ling, FU Rao, SHA Meng, WU Yi. Effect of 5A nursing model on self-management ability of patients with primary hypertension[J]. Journal of Clinical Medicine in Practice, 2022, 26(19): 111-114. DOI: 10.7619/jcmp.20221615
    [2]WANG Xuemei, HOU Jianhong, SONG Juan. Influence of continued nursing on postoperative comprehensive ability of patients after craniotomy in neurosurgery department[J]. Journal of Clinical Medicine in Practice, 2018, (8): 39-42. DOI: 10.7619/jcmp.201808012
    [3]ZHANG Yan, GAO Shan, YANG Dan, PAN Yanfei, JIANG Shuyan. Effect of single disease nursing quality standards on blood glucose, compliance and self-management ability in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2017, (6): 45-48. DOI: 10.7619/jcmp.201706014
    [4]ZHANG Yu. Effect of the continued self-management education on the health knowledge level and self-care ability of patients with CHD[J]. Journal of Clinical Medicine in Practice, 2017, (6): 4-7. DOI: 10.7619/jcmp.201706002
    [5]YANG Zhenzhen, JIN Ziyu. Influence of continuity nursing intervention on quality of life and nursing satisfaction of patients with cervical cancer after operation[J]. Journal of Clinical Medicine in Practice, 2017, (4): 125-128. DOI: 10.7619/jcmp.201704038
    [6]FENG Chunmei, JIANG Xufeng. Effect of refined nursing management on controlling postoperative pain and infection in generalsurgery department[J]. Journal of Clinical Medicine in Practice, 2017, (4): 104-107. DOI: 10.7619/jcmp.201704032
    [7]ZHENG Yingxian. Impact of continuous nursing intervention on self-care ability and life quality of elderly patients with repeated respiratory infection[J]. Journal of Clinical Medicine in Practice, 2017, (4): 50-52,59. DOI: 10.7619/jcmp.201704016
    [8]ZHANG Wenying, GUO Yan. Investigation on self-management ability of PICC catheter in breast cancer patients with chemotherapy and nursing countermeasures[J]. Journal of Clinical Medicine in Practice, 2016, (10): 58-60,64. DOI: 10.7619/jcmp.201610019
    [9]LIU Rongying, MA Shuang, PAN Huaying, JIANG Yan, ZHAO Jing. The effect of continuous nursing on families'adverse psychological and self-care ability of esophageal cancer patients[J]. Journal of Clinical Medicine in Practice, 2015, (22): 44-47. DOI: 10.7619/jcmp.201522015
    [10]JIN Shiling. Effect of continuous nursing on self-care and prognosis of chronic heart failure patients[J]. Journal of Clinical Medicine in Practice, 2015, (12): 4-7. DOI: 10.7619/jcmp.201512002
  • Cited by

    Periodical cited type(11)

    1. 岳佳丽,海光,雷卓颖,王丽君. 环硅酸锆钠联合肾素-血管紧张素-醛固酮系统抑制剂治疗慢性肾脏病的机制和效果的研究进展. 中国医药导报. 2024(16): 188-190 .
    2. 竹琳,郑浩天,万正红,何莉,周莉. 血液透析患者高钾血症相关领域研究热点及发展动态的可视化分析. 华西医学. 2024(08): 1259-1264 .
    3. 黄湘干,赵艳,关毅标,翁春亮,谢双燕. 维持性血液透析患者高钾血症发生的相关因素分析. 现代医学与健康研究电子杂志. 2024(21): 116-119 .
    4. 董生荣,景舒梦,苟伟康,房浩亮,刘彬彬,刘永峰. 环硅酸锆钠治疗围透析期患者慢性高钾血症的有效性研究. 中国卫生标准管理. 2023(02): 140-143 .
    5. 陈丽,常文秀. 环硅酸锆钠散治疗慢性肾脏病高钾血症的临床研究. 现代诊断与治疗. 2023(05): 700-703 .
    6. 陈文文,方芦炜,丁越越,马红珍. 马红珍教授治疗慢性肾病伴高钾血症的中药应用策略. 浙江中医药大学学报. 2023(08): 874-879 .
    7. 蔡享兰. 不同剂量肾康注射液辅助治疗慢性肾脏病3~5期的效果及对肾功能的影响. 中国医学创新. 2023(30): 49-53 .
    8. 宋欣芫,常文秀. 慢性肾脏病5期合并高钾血症饮食干预1例报告. 中国实用内科杂志. 2022(05): 438-440 .
    9. 张灿,王静. 慢性肾脏疾病患者血钾异常的影响因素及对预后的影响研究. 医药论坛杂志. 2022(13): 20-23 .
    10. 刘环,罗琰琨,王晨丹. 环硅酸锆钠散治疗慢性高钾血症1例. 中国医药. 2022(12): 1877-1879 .
    11. 丁苗佳,沈水娟,吴佳盈. 新型口服降钾药物环硅酸锆钠治疗慢性肾脏病高钾血症临床进展. 中国医药科学. 2021(21): 66-69 .

    Other cited types(6)

Catalog

    Article views (112) PDF downloads (5) Cited by(17)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return